E2 ModerateModerate confidencePEM not requiredCase-ControlPeer-reviewedReviewed
Affective and chronic fatigue symptoms are associated with serum neuronal damage markers in Parkinson's disease.
Al-Hakeim, Hussein Kadhem, Khudhair, Hayder Naji, Ranaei-Siadat, Sayed-Omid et al. · Scientific reports · 2025 · DOI
Quick Summary
This study looked at people with Parkinson's disease who also experienced depression and extreme fatigue, similar to ME/CFS. Researchers found that certain proteins in the blood that signal brain cell damage were elevated in these patients, and these proteins were connected to inflammation, blood sugar problems, and the mood and fatigue symptoms they experienced.
Why It Matters
This research is relevant to ME/CFS because it identifies a potential biological mechanism linking neuroinflammation, metabolic dysfunction, and fatigue/mood symptoms. The findings suggest that measuring serum brain injury markers and metabolic parameters may help understand ME/CFS pathophysiology and could inform future biomarker-driven treatment strategies.
Observed Findings
- PD patients had significantly higher affective and CFS symptom scores compared to healthy controls.
- Serum levels of NSE, GFAP, pTau217, and S100B were elevated in PD patients versus controls.
- Immune inflammatory markers (IL-6, IL-10) and insulin resistance (HOMA2IR) were increased in PD patients.
- NSE, S100B, HOMA2IR, and IL-10 together explained 52.5% of the variance in mood + CFS composite scores.
- Immune/metabolic indices collectively explained 37% of variance in the four brain injury biomarkers.
Inferred Conclusions
- Immune activation and insulin resistance in PD contribute to glial cell and neuronal damage, which in turn contributes to affective and fatigue symptoms.
- Serum neuronal injury biomarkers appear to be biological correlates of mood and fatigue symptoms in PD.
- Metabolic dysfunction (insulin resistance) and systemic inflammation may be mechanistically linked to neuronal damage in PD-associated fatigue and depression.
Remaining Questions
- Do these biomarkers and mechanisms also operate in primary ME/CFS patients without Parkinson's disease?
- Is the relationship between immune/metabolic dysfunction and neuronal damage markers causal, bidirectional, or mediated by other factors?
What This Study Does Not Prove
This study does not prove that the identified biomarkers cause fatigue and mood symptoms—only that they are associated. The study focused on Parkinson's disease patients, not ME/CFS patients, so direct applicability to ME/CFS remains uncertain. Cross-sectional design prevents determination of temporal relationships and causality.
Tags
Symptom:FatigueCognitive Dysfunction
Biomarker:CytokinesBlood Biomarker
Method Flag:Weak Case DefinitionSmall SampleExploratory Only
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.